Skip to main content
. 2015 Mar 19;12(1):988–994. doi: 10.3892/mmr.2015.3515

Figure 2.

Figure 2

Effect of GLGZD on the development of behavioral abnormalities following MCAO. Neurological score was taken as index. Values are expressed as the mean ± standard deviation in each group. 0 indicates no neurological symptoms, 1 indicates inability fully flex the left forepaw, 2 indicates rotating while crawling and falling to the contralateral side, 3 indicates inability to walk unaided and 4 indicates unconsciousness. **P<0.01 vs. sham-surgery group, #P<0.05, ##P<0.01, vs. MCAO model group. MCAO, middle cerebral artery occlusion; GLGZD, Gualou Guizhi decoction; GLGZD-1, rats that were administered 7.2 g/kg GLGZD; GLGZD-2, rats that were administered 14.4 g/kg GLGZD.